Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONWARD: Cladribine Add-on to IFN-beta in Active MS
NCT00436826Phase 2Completed
- Sponsor
- EMD Serono
- Start
- Nov 2006
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of cladribine in multiple sclerosis (MS), sponsored by EMD Serono. Started Nov 2006; status: completed.
02
Drugs
cladribine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00436826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436826.